Head-To-Head Review: Catasys (CATS) & Hanger (HNGR)

Catasys (NASDAQ: CATS) and Hanger (OTCMKTS:HNGR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation.

Profitability

This table compares Catasys and Hanger’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Catasys -146.80% N/A -210.45%
Hanger N/A N/A N/A

Valuation & Earnings

This table compares Catasys and Hanger’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Catasys $7.07 million 7.80 -$17.93 million ($1.75) -1.98
Hanger $1.01 billion 0.52 -$18.96 million ($0.09) -160.44

Catasys has higher earnings, but lower revenue than Hanger. Hanger is trading at a lower price-to-earnings ratio than Catasys, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

6.4% of Catasys shares are owned by institutional investors. Comparatively, 3.8% of Hanger shares are owned by institutional investors. 92.2% of Catasys shares are owned by company insiders. Comparatively, 2.4% of Hanger shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Catasys and Hanger, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Catasys 0 1 1 0 2.50
Hanger 0 0 0 0 N/A

Catasys presently has a consensus price target of $8.00, suggesting a potential upside of 130.55%. Given Catasys’ higher probable upside, research analysts clearly believe Catasys is more favorable than Hanger.

Volatility and Risk

Catasys has a beta of -0.3, suggesting that its share price is 130% less volatile than the S&P 500. Comparatively, Hanger has a beta of 4.51, suggesting that its share price is 351% more volatile than the S&P 500.

Summary

Catasys beats Hanger on 6 of the 11 factors compared between the two stocks.

Catasys Company Profile

Catasys, Inc. provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services. Its OnTrak solution combines medical and psychosocial treatments with elements of traditional disease management, case management, and ongoing member support to help organizations treat and manage populations struggling with substance dependence, depression, and anxiety to improve their health and thereby decrease their health care costs. Catasys, Inc.’s OnTrak solution includes various components, such as identification of impactable members, member engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2000 and is based in Los Angeles, California.

Hanger Company Profile

Hanger, Inc. is a rehabilitative product and service company. The Company delivers orthotic and prosthetic (O&P) patient care, products, services and therapeutic solutions. The Company offers advanced prosthetics and orthotics, clinically differentiated programs and unsurpassed customer service. The Company comprises nine business units that serve various segments of the O&P industry. The Company’s segments include Patient Care, and Products & Services. The Patient Care segment includes Hanger Clinic and Linkia. The Hanger Clinic specializes in orthotic and prosthetic services and products. Linkia is a specialty healthcare company, which is engaged in the O&P management and care. The Products & Services segment includes Southern Prosthetic Supply (SPS), Accelerated Care Plus (ACP), SureFit, Innovative Neurotronics, Inc. and SPS National Labs.

What are top analysts saying about Catasys Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Catasys Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit